stars 1 stars 2 stars 3

Aminex Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of a novel small molecule combination therapy for the treatment of a broad range of cancer indications. Aminex has advanced AMXT 1501 + DFMO through target discovery, patenting, pre-clinical research and now into clinical development for the potential benefit of cancer patients.

Aminex Therapeutics Questions

The Aminex Therapeutics annual revenue was $811000 in 2026.

Mark Burns is the Founder, President and CSO of Aminex Therapeutics.

6 people are employed at Aminex Therapeutics.

Aminex Therapeutics is based in Kirkland, Washington.

The NAICS codes for Aminex Therapeutics are [54, 541711, 54171, 541, 99, 5417].

The SIC codes for Aminex Therapeutics are [80, 283, 28].

Top Aminex Therapeutics Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Winter 2026 G2 Leader Mid Market Winter 2026 G2 Leader Small Business Winter 2026 G2 Most Implementable Winter 2026 G2 Best Est ROI Mid Market Winter 2026 G2 Leader Momentum Winter 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users